Kushwaha VK

References (3)

Title : Benzothiazole-driven molecular probes and therapeutics for neurodegenerative diseases: focus on amyloid-beta (Abeta), tau, and alpha-synuclein - Kumar_2026_RSC.Med.Chem__
Author(s) : Kumar N , Khan I , Singh J , Kumar K , Kushwaha VK , Kumar S , Ojha S , Dash AK , Shankar G
Ref : RSC Med Chem , : , 2026
Abstract :
PubMedSearch : Kumar_2026_RSC.Med.Chem__
PubMedID: 42662146

Title : Rivastigmine-centered molecular hybridization strategies for multi-targeted intervention in Alzheimer's disease: Advances (2020-2026) - Kumar_2026_Bioorg.Med.Chem_143_118811
Author(s) : Kumar N , Kushwaha VK , Singh G , Ojha S , Dash AK , Shankar G
Ref : Bioorganic & Medicinal Chemistry , 143 :118811 , 2026
Abstract :
PubMedSearch : Kumar_2026_Bioorg.Med.Chem_143_118811
PubMedID: 42810176

Title : Recent developments in donepezil-based hybrid molecules as multi-target therapeutics for Alzheimer's disease: A paradigm shift beyond symptomatic treatment - Kumar_2026_Bioorg.Chem_181_110361
Author(s) : Kumar N , Khan I , Singh J , Kumar K , Kushwaha VK , Ojha S , Raman SK , Shankar G
Ref : Bioorg Chem , 181 :110361 , 2026
Abstract :
PubMedSearch : Kumar_2026_Bioorg.Chem_181_110361
PubMedID: 42600466